Release Date: 09/06/17 08:43 Summary: VivoPower announces results and confirms upgraded guidance Price Sensitive: Yes Download Document 513.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%